Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-upc
/
Universe Pharmaceuticals Inc
UPC
4.490
USD
+0.340
+8.19%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
2.53M
Market Cap
--
P/E TTM
Universe Pharmaceuticals Inc
4.490
+0.340
+8.19%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
Total revenue
-26.74%
10.14M
-30.23%
12.88M
-13.17%
13.84M
-23.70%
18.47M
--
15.94M
--
24.20M
Revenue
-26.74%
10.14M
-30.23%
12.88M
-13.17%
13.84M
-23.70%
18.47M
--
15.94M
--
24.20M
Cost of revenue
-22.96%
7.44M
-22.89%
9.52M
23.68%
9.65M
18.12%
12.34M
--
7.81M
--
10.45M
Operating expenses
-8.56%
16.42M
-20.16%
14.62M
-30.02%
17.96M
-14.80%
18.32M
--
25.66M
--
21.50M
R&D expenses
12.65%
2.92M
-96.71%
74.70K
-65.46%
2.59M
1470.21%
2.27M
--
7.50M
--
144.46K
Depreciation, depletion, and amortization
-5.63%
236.87K
-3.46%
248.86K
3.79%
251.00K
-11.75%
257.78K
--
241.84K
--
292.11K
Operating profit
-52.59%
-6.28M
-1265.95%
-1.74M
57.66%
-4.12M
-94.47%
149.25K
--
-9.72M
--
2.70M
Net non-operating interest income (expenses)
Non-operating interest expense
--
141.56K
--
136.61K
--
--
--
--
--
--
--
--
Return on equity
2.80%
31.94K
--
--
-19.48%
31.07K
--
--
--
38.59K
--
0.00
Special income (expenses)
--
7.62M
--
-7.62M
--
--
--
--
--
--
--
--
Other non-operating income (expenses)
835.36%
3.09M
-1696.74%
-2.94M
35.22%
-419.87K
-73.57%
184.25K
--
-648.12K
--
697.06K
Income before tax
194.10%
4.32M
-4902.94%
-12.44M
55.92%
-4.59M
-92.18%
258.93K
--
-10.40M
--
3.31M
Income tax
-104.57%
-58.44K
-31.73%
665.15K
267.68%
1.28M
-38.26%
974.36K
--
-762.90K
--
1.58M
Income after tax
174.57%
4.37M
-1731.28%
-13.10M
39.16%
-5.87M
-141.31%
-715.43K
--
-9.64M
--
1.73M
Net income from continuous operations
174.57%
4.37M
-1731.28%
-13.10M
39.16%
-5.87M
-141.31%
-715.43K
--
-9.64M
--
1.73M
Net income attributable to controlling interests
174.57%
4.37M
-1731.28%
-13.10M
39.16%
-5.87M
-141.31%
-715.43K
--
-9.64M
--
1.73M
Net income attributable to common shareholders
174.57%
4.37M
-1731.28%
-13.10M
39.16%
-5.87M
-141.31%
-715.43K
--
-9.64M
--
1.73M
Basic earnings per share
120.70%
200.99
-1720.73%
-2.16K
39.16%
-970.75
-141.31%
-118.42
--
-1.60K
--
286.63
Diluted earnings per share
120.70%
200.99
-1720.73%
-2.16K
39.16%
-970.75
-141.31%
-118.42
--
-1.60K
--
286.63
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up